Medicines for Europe Legal Affairs Conference

Mishcon de Reya IP Partner David Rose last week spoke at Medicines for Europe Legal Affairs Conference in London – a ‘ forum of high level discussions between leading industry executives and experts, counsel and European institution officials on the latest IP legal landscape developments with regard to generic, biosimilar and value added medicines in Europe and worldwide.’

Following the conference, David was quoted in an article UPC deal uncertain in shadow of Brexit in Generics Bulletin, discussing the potential impact of the UK’s vote to leave the European Union:

‘David Rose, of Mishcon de Reya, raised the possibility of the UK “tinkering” with SPC [Supplementary Protection Certificate] arrangements once the UK regime was separate, but warned this could create an “un-level playing field with the EU”.’